Decreased tumor incidence, oxidative DNA damage, phase I enzyme activitiesReduction in CYP1A1 and CYP1B1Enhanced phase II enzyme activities in the buccal pouch and liver. This evidence concerns the gene CYP1A1 and neoplasm.